期刊文献+

组蛋白乙酰化修饰失衡在心肌肥厚中的作用

下载PDF
导出
摘要 心肌肥厚是多种心血管疾病发生发展过程中的一个重要阶段。组蛋白乙酰化修饰失衡参与了心肌肥厚的发病过程,多种组蛋白乙酰化酶可调控心脏发育相关转录因子的转录活性,而组蛋白乙酰化酶特异性抑制剂能够逆转组蛋白高乙酰化状态并修复这一病理过程。该文主要介绍表观遗传学中组蛋白乙酰化酶介导的组蛋白乙酰化修饰失衡对心肌肥厚的影响。
作者 彭昌 田杰
出处 《国际心血管病杂志》 2016年第5期283-285,共3页 International Journal of Cardiovascular Disease
基金 国家自然科学基金(81560040)
  • 相关文献

参考文献28

  • 1Greco CM, Condorelli G. Epigenetic modifications and noneoding RNAs in cardiac hypertrophy and failure [J]. Nat Rev Cardiol, 2015,12(8) :488-497.
  • 2Wang Y, Miao X, Liu Y, et al. Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseases [J]. Oxid Med Cell Longer, 2014,2014:641979.
  • 3曹珊珊,苏永立,李瑞芳,王建刚,方伟进,岳阳阳.Ⅰ型组蛋白去乙酰化酶在心肌肥厚中的靶点作用[J].国际心血管病杂志,2013,40(6):359-361. 被引量:1
  • 4Sadoul K, Boyault C, Pabion M, et al. Regulation of protein turnover by acetyltransferases and deacetylases [J ]. Biochimie, 2008,90(2) :306-312.
  • 5Yang XJ, Scto E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention [J]. Oncogene, 2007,26(37) :5310-5318.
  • 6Mujtaba S, Zeng L, Zhou MM. Structure and acetyl-lysine recognition of the bromodomain [J]. Oncogene, 2007, 26 (37) : 5521-5527.
  • 7Wei JQ, Shehadeh LA, Mitrani JM, et al. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300 [J]. Circulation, 2008,118 ( 9 ) : 934-946.
  • 8Chen X, Qin L, Liu Z, et al. Knockout of SRC-1 and SRC-3 in mice decreases cardiomyocyte proliferation and causes a noncompaction cardiomyopathy phenotype [J]. Int J Biol Sci, 2015,11 (9) : 1056-1072.
  • 9Li L, Zhu J, Tian J, et al. A role for Gcn5 in cardiomyocyte differentiation of rat mesenchymal stem cells [J]. Mol Cell Biochem, 2010,345(1-2) :309-316.
  • 10Lin W, Srajer G, Evrard YA, et al. Developmental potential of Gcn5(-/-) embryonic stem cells in vivo and in vitro [J]. Dev Dyn, 2007,236(6) : 1547-1557.

二级参考文献65

  • 1Clocchiatti A, Di Giorgio E, Ingrao S, et al. Class IIa HDACs repressive activities on MEF2 depedent transcription are associated with poor prognosis of ER: breast tumors [J]. FASEB, 2013, 27 (3): 942-954.
  • 2Min SK, Koh YH, Park Y, et al. Expression of HAT1 and HDAC1, 2, 3 in Diffuse Large B-Cell Lymphomas, Peripheral T-Cell Lymphomas, and NK/T-Cell Lymphomas [J]. Korean J Pathol, 2012, 46(2): 142-150.
  • 3Dobaczewski M, Bujak M, Li N, et al. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction [J]. Circ Res, 2010, 107(3): 418-428.
  • 4Shah RR, Koniski A, Shinde M, et al. Regulation of primitive hematopoiesis by class I histone deacetylases [J]. Dev Dyn, 2013, 242(2): 108-121.
  • 5Tang J, Yan H, Zhuang S. Histone deacetylases as targets for treatment of multiple diseases [J]. Clin Sci, 2013, 124(11) : 651-662.
  • 6Deubzer HE, Schier MC,Oehme I. HDACll is a novel drug target in carcinomas [J]. Int J Cancer, 2013, 132(9) : 2200- 2208.
  • 7Sato T, Kotake D, Hiratsuka M, et al. Enhancement of inflammatory protein expression and nuclear factor Kb (NF Kb) activity by trichostatin A (TSA) in OP9 preadipoeytes [J]. PI:oS One, 2013, 8(3) : e59702.
  • 8Zhao L, Chen CN, Hajji N, et al. Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid [J ]. Circulation, 2012, 126(4): 455-467.
  • 9Larsson P, Ulfhammer E, Magnusson M, et al. Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue type plasminogen activator expression [J]. PLoSOne, 2012, 7(2): e31573.
  • 10Von Mevenn F, Porstmann T, Gasser E, et al. Glueagon- induced acetylation of foxa2 regulates hepatic lipid metabolism [J]. Cell Metab, 2013, 17(3): 436-447.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部